PARIS (Reuters) - Biomérieux, a French healthcare company specialising in diagnostics, said on Monday it had won more positive feedback from the U.S. Food & Drug Administration (FDA) regulator for its ...

BioMerieux has a niche position in syndromic testing, which refers to using a single test for a large number of pathogens at the same time, and the company holds about 80% of the market, with ...

BioMerieux has a niche position in syndromic testing, which refers to using a single test for a large number of pathogens at the same time, and the company holds about 80% of the market, with ...

Add Yahoo as a preferred source to see more of our stories on Google. Covid-19 at home Rapid Test Kit The FDA has extended the shelf life for some COVID-19 tests. Now that allergy season is here, many ...

“To effectively respond to the COVID-19 pandemic, Africa needs continuous and predictable supply of diagnostics and medical consumables, and the AMSP was created to close the supply gap. Through AMSP ...

Add Yahoo as a preferred source to see more of our stories on Google. an iHealth COVID-19 antigen rapid test kit The federal government may destroy its remaining supply of COVID-19 tests. The US ...

You don't need a prescription to purchase a test that will tell you whether you're sick with COVID or the flu. Jessica was a writer on the Wellness team, with a focus on health technology, eye care, ...